[ Price : $8.95]
Federal Register notice: FDA releases a final guidance on using placebos and allowing blinding in cancer clinical trials.[ Price : $8.95]
AstraZeneca says that the Phase 3 TULIP 2 trial for anifrolumab, an investigational drug for treating systemic lupus erythematosus...[ Price : $8.95]
Stakeholders praise and criticize an FDA draft guidance on a benefit/risk assessment framewok for opioids.[ Price : $8.95]
An FDA safety alert recommends that healthcare providers transition to duodenoscopes with innovative designs that are more safe an...[ Price : $8.95]
FDA issues two final guidances explaining its views on making benefit/risk determinations for certain medical device approval appl...[ Price : $8.95]
FDA issues an FDA-483 with eight observations from an inspection at Dr. Reddys drug manufacturing facility in Andhra, Pradesh, Ind...[ Price : $8.95]
FDA grants Emalex Biosciences a fast track designation for its investigational drug ecopipam for treating patients with Tourette S...[ Price : $8.95]
FDA releases a final guidance on use of placebos and blinding in cancer clinical trials.